Purdue University will be hosting a virtual retreat for the Indiana Clinical and Translational Sciences Institute (CTSI) on Tuesday, February 22, 2022. The theme will be, “Preclinical Innovation of Biomedical Translational Research.”
Christopher Austin, MD, former director of National Center for Advancing Translational Sciences, will be the keynote speaker.
Christopher Austin, MD, joined Flagship Pioneering in 2021 as a CEO Partner. Chris is part of the broader Flagship senior leadership team and also serves as Chief Executive Officer of a Flagship-founded company currently in stealth and to be announced at a later date. Chris is a trained clinician and geneticist, with more than 20 years of experience in translational research in both the public and private sectors. He joined Flagship from the National Institutes of Health (NIH) where he served as the founding Director of the National Center for Advancing Translational Sciences (NCATS).
The retreat aims to inform the audience on three broad topics:
1. Optimizing technologies and capabilities to reach successful preclinical data collection
2. Introducing innovative preclinical models and their advantages
3. Designing preclinical studies to support academic and industry partnership and FDA approval
More details will be shared in the future.
